Company Filing History:
1 out of 41 
1 out of 832,880 Years Active: 1999-2003
Title: Mary Susan Anthony: Innovator in Neurodegeneration Treatment
Introduction: Mary Susan Anthony, based in Clemmons, North Carolina, is a notable inventor recognized for her contributions to the field of medical treatments for cognitive decline associated with Alzheimer's disease and similar disorders. With two patents to her name, she has made significant strides in developing compositions aimed at alleviating memory impairments.
Latest Patents: Among her latest patents is the groundbreaking invention titled "Compositions and Methods for Treating or Preventing Neurodegeneration and Cognitive Decline and Dysfunction Associated with Alzheimer's Disease, Aging, Other Dementia Related Disorders and Estrogen Deficiency Related Conditions." This innovative composition combines at least one phytoestrogen with an acetylcholinesterase inhibitor, such as Huperzine A, to improve memory and concentration in mammals suffering from memory-related disorders. Additionally, her methods for inhibiting the development of Alzheimer's disease leverage phytoestrogenic isoflavone compounds, effectively targeting individuals predisposed to Alzheimer's or suffering from its symptoms.
Career Highlights: Throughout her career, Mary Susan Anthony has worked with Protein Technologies International, Inc., where she honed her expertise in neurodegenerative research and treatment development. Her extensive work reflects her commitment to finding innovative solutions for cognitive health issues, highlighting her influence in the pharmaceutical and biotechnology sectors.
Collaborations: Mary has collaborated with notable professionals in her field, including Yuanlong Pan and Thomas Boston Clarkson, Jr. These partnerships have enriched her research efforts and expanded the scope of her innovative contributions to the understanding and treatment of cognitive decline.
Conclusion: Mary Susan Anthony stands out as an influential inventor whose work is vital in the ongoing fight against Alzheimer's disease and related disorders. Her patents encapsulate her dedication to enhancing cognitive health and provide promising avenues for future research and development in neurodegeneration treatments.